The International Conference on Recent Advances in Medical, Medicine, and Health Sciences (ICRAMMHS), scheduled from March 20th to 21st, 2024 in Las Vegas, USA, aims to unite pioneering scholars and industry experts in Business Management and Social Innovation. Recognized by numerous international institutes, the conference promises insights from distinguished speakers nationwide. Papers will be published by the World Research Library and submitted for Google Scholar indexing. Best paper awards await exceptional contributions. Rigorous peer review ensures quality, covering diverse research topics. Proceedings with ISBN and select papers published in prestigious Scopus/SCI/WoS/UGC Care Listed journals ensure broad dissemination of findings.

Read on wrfer.org

The International Conference on Recent Advances in Medical Science (ICRAMS) is scheduled for March 20-21, 2024, in San Diego, USA, sponsored by the International Institute of Engineers and Researchers (IIER). Established in 2014, ICRAMS annually provides a global platform for researchers and practitioners to share groundbreaking developments in Medical Science. This event aims to facilitate collaboration and knowledge exchange among experts worldwide. The conference covers diverse scientific areas, fostering communication and enhancing techniques related to Recent Advances in Medical Science. Leading researchers, engineers, and scientists from various corners of the globe will converge to present and discuss technological advancements and research findings in the field.

Read on theiier.org

The International Research Conference is dedicated to uniting diverse scholarly events within its program, offering exceptional value to students, academics, and industry researchers. The International Conference on Healthcare and Telemedicine gathers prominent academic scientists, researchers, and scholars to exchange experiences and research findings in all areas of Healthcare and Telemedicine. This conference serves as an interdisciplinary platform for presenting and discussing recent innovations, trends, concerns, challenges, and solutions in the fields of Healthcare and Telemedicine.

Read on waset.org

The Research Conferences organize the International Conference on Medical, Medicine, and Health Science (RICMMHS) scheduled for March 19th-20th, 2024. This conference serves as a focal point for leading academic scientists, researchers, and scholars to convene and share their insights and research findings across all facets of Medical, Medicine, and Health Sciences. RICMMHS offers a prime interdisciplinary platform fostering the exchange of ideas among researchers, practitioners, and educators. It aims to explore recent innovations, emerging trends, and address practical challenges in the dynamic fields of Medical, Medicine, and Health Sciences, contributing to the advancement and collaboration within these domains.

Read on researchconferences.in

The International Conference on Bioinformatics, Biomedicine, Biotechnology, and Computational Biology (EUIC3BCB) is scheduled for March 19th, 2024, in Louisville, United States. This recurring conference series facilitates an interactive platform for the presentation and discussion of advancements in Bioinformatics, Biomedicine, Biotechnology, and Computational Biology. Welcoming global participants, the event serves as a forum for establishing professional connections, exploring career opportunities, and fostering collaborations. Professionals from diverse sectors, including research, academia, industry, and government organizations, converge to exchange knowledge and gain insights into the latest technologies, techniques, and solutions in Biotechnology applied worldwide, contributing to the advancement of these fields.

Read on eurasiaweb.com

Engage in advancing personalized therapies for rare and common kidney diseases at the 6th CKD Drug Development Summit from March 19 to 21, 2024. Explore groundbreaking clinical strides like SGLT2s, GLP-1s, and ERAs for CKD. Delve into enhanced surrogate markers for outcomes, new targets, and pioneering research. This summit unites 200+ biopharma stakeholders across scientific, clinical, and outcomes realms for three days of focused discourse. The premier platform for industry leaders, regulators, and experts to propel kidney innovation toward the future of drug development.

Read on ckd3-summit.com

The 4th Wet AMD and Diabetic Eye Disease Drug Development Summit returns to Boston this March, gathering over 70 industry-based retinal vascular experts from renowned companies like Bayer, Boehringer Ingelheim, Genentech, Novartis, and OcuTerra. This dedicated forum aims to revolutionize the treatment of chronic, sight-threatening retinal vascular diseases, enhancing patient outcomes. The 2024 event features new contributors such as Aviceda Therapeutics, Adverum Biotechnologies, and others, presenting compelling content on novel targets, retinal imaging, clinical biomarkers, and innovative modalities for retinal and choroidal neovascularization. Scheduled from Tue, March 19, 2024, at 08:00 to Thu, March 21, 2024, at 15:00.

 [Read on wet-amd-drug-development.com](https://wet-amd-drug-development.com/)

The 4th TPD Summit Europe returns as the foremost gathering for Targeted Protein Degradation professionals in Europe and globally. Scheduled from Tue, 19 Mar 2024, at 08:00 to Thu, 21 Mar 2024, at 17:30, the summit explores novel degrader development, E3 ligase/ligand discovery, and overcoming safety concerns in PROTACs. With 35+ experts, it covers degrader drug development, from hit finding to clinical candidate assessment, fostering connections among 110+ professionals for revolutionary advancements benefiting patients worldwide.

 [Read on tpd-europe.com](https://tpd-europe.com/)

Join the pivotal 4th Operationalize Expanded Access Programs Summit in Boston from March 19th to March 21st, 2024, addressing the burgeoning interest in patient access to investigational medicines. This unique industry forum unites over 120 experts shaping Expanded Access Programs (EAPs), providing invaluable insights into global regulations, constructing reliable systems, and leveraging real-world data. Network with managed access teams from top pharmaceutical companies like Novartis, GSK, AstraZeneca, and more to explore innovative strategies, optimize EAP operationalization, and efficiently deliver life-saving treatments to patients. Don't miss this opportunity to join passionate EAP and clinical supply experts, physicians, and patients in revolutionizing access to vital therapies.

Read on operationalize-eap.com

The 3rd Cell Therapy Potency Assay Summit (Tue, 19 Mar 2024 - Thu, 21 Mar 2024) addresses the pressing challenge of developing robust potency assays within the dynamic cell therapy landscape. With recent clinical holds experienced by Mesoblast and Verve Therapeutics highlighting this need, over 120 analytical, quality control, and regulatory experts convene to collaboratively design more effective assays. This gathering aims to scientifically link mechanisms of action to potency assays, ensuring streamlined regulatory approval and reduced hold times. Industry insights from leading organizations like BMS, J and J, Atara Biotherapeutics, Fate Therapeutics, Health Canada, among others, offer valuable perspectives for developing reproducible assays, providing comprehensive understanding across different cell types and indications in autologous and allogeneic cell therapies.

Read on www.cell-therapy-potency-assay.com